Skip to main content

Table 2 Factors associated with undetectable viral load among PLHIV on ART from 2016 to 2020 in Northern Tanzania (N = 416)

From: HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania

Characteristics

Unadjusted

p-value

Adjusted

p-value

 

RR (95% CI)

 

RR (95% CI)

 

Age group (in years)

    

6–14

1.00

 

1.00

 

15–24

1.43 (0.82–2.48)

0.204

1.44 (0.78–2.67)

0.249

25–54

1.37 (0.88–2.14)

0.164

1.33 (0.78–2.26)

0.297

55+

1.39 (0.89–2.21)

0.157

1.33 (0.77–2.31)

0.308

Sex

    

Male

1.00

 

1.00

 

Female

1.13 (0.98–1.29)

0.086

1.06 (0.93–1.22)

0.379

Marital status

    

Single

1.00

 

1.00

 

Married/Cohabiting

0.94 (0.79–1.11)

0.449

0.99 (0.82–1.19)

0.910

Divorced/Separated

0.99 (0.82–1.21)

0.985

1.01 (0.81–1.26)

0.908

*Current BMI (kg/m2)

    

Underweight

0.88 (0.64–1.22)

0.443

0.94 (0.69–1.28)

0.699

Normal

1.00

 

1.00

 

Overweight

1.11 (0.94–1.31)

0.208

1.17 (0.99–1.37)

0.059

Obesity

1.25 (1.08–1.45)

0.003

1.21 (1.03–1.42)

0.023

HIV Stage

    

Stage I

1.00

 

1.00

 

Stage II

1.01 (0.86–1.17)

0.948

1.00 (0.86–1.17)

0.984

Stage III

0.76 (0.64–0.91)

0.002

0.77 (0.65–0.91)

0.003

Stage IV

0.86 (0.65–1.14)

0.294

0.92 (0.71–1.19)

0.515

ART regimen

    

First line

1.29 (0.79–2.07)

0.303

0.96 (0.56–1.63)

0.878

Second line

1.00

 

1.00

 

*Visit status

    

1–2

1.00

 

1.00

 

3

1.42 (1.13–1.79)

0.003

1.36 (1.08–1.72)

0.009

4–6

1.36 (1.08–1.71)

0.010

1.29 (1.03–1.63)

0.029

Treatment supporter

    

No

1.00

 

1.00

 

Yes

0.96 (0.79–1.16)

0.661

0.99 (0.81–1.21)

0.913

ART adherence

    

Poor

1.00

 

1.00

 

Good

1.46 (0.88–2.44)

0.142

1.46 (0.89–2.39)

0.131

  1. Key RR: Relative risk, 1: Reference.* Visits status is defined as number of visits done per year. E.g.; 1–2 the person, went to the clinic after every 6–12months